Reaction
Lung Diffusion Disorder reporting signals
As of the last recalculation, Lung Diffusion Disorder appears in 156 FAERS reports alongside 10 co-occurring drug terms. The strongest observed disproportionality signal is CICLESONIDE (PRR 211.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ciclesonide | 19 | 211.8 | 212.1 |
| Fluticasone Furoate | 15 | 182.7 | 182.9 |
| Nicotine Polacrilex Mini | 18 | 180.8 | 181.0 |
| Nicotine Polarilex | 18 | 180.8 | 181.0 |
| Mepolizumab | 38 | 134.6 | 134.7 |
| Tiotropium Bromide Inhalation Spray | 8 | 100.3 | 100.4 |
| Fluticasone Furoate And Vilanterol Trifenatate | 20 | 85.0 | 85.0 |
| Nicotine | 19 | 71.2 | 71.3 |
| Nicotine Polacrilex | 18 | 70.8 | 70.8 |
| Pirfenidone | 10 | 34.9 | 35.0 |